Neogenomics Stock Price on August 9, 2024

NEO Stock  USD 17.73  0.17  0.95%   
Below is the normalized historical share price chart for NeoGenomics extending back to November 10, 1999. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NeoGenomics stands at 17.73, as last reported on the 13th of December 2024, with the highest price reaching 18.02 and the lowest price hitting 17.47 during the day.
IPO Date
2nd of November 1999
200 Day MA
15.0286
50 Day MA
15.1696
Beta
1.183
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in NeoGenomics Stock, it is important to understand the factors that can impact its price. As of now, NeoGenomics Stock is not too volatile. NeoGenomics has Sharpe Ratio of 0.0568, which conveys that the firm had a 0.0568% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for NeoGenomics, which you can use to evaluate the volatility of the firm. Please verify NeoGenomics' Mean Deviation of 1.92, downside deviation of 2.48, and Risk Adjusted Performance of 0.0567 to check out if the risk estimate we provide is consistent with the expected return of 0.15%.
  
At this time, NeoGenomics' Sale Purchase Of Stock is very stable compared to the past year. As of the 13th of December 2024, Stock Based Compensation To Revenue is likely to grow to 0.04, while Common Stock Total Equity is likely to drop about 102.7 K. . As of the 13th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.61, while Price To Sales Ratio is likely to drop 3.26. NeoGenomics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0568

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskNEOHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.57
  actual daily
22
78% of assets are more volatile

Expected Return

 0.15
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average NeoGenomics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeoGenomics by adding it to a well-diversified portfolio.
Price Book
2.568
Enterprise Value Ebitda
(27.92)
Price Sales
3.6209
Shares Float
126.6 M
Wall Street Target Price
21

NeoGenomics Main Headline on 9th of August 2024

Filed transaction by NeoGenomics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

NeoGenomics Valuation on August 9, 2024

It is possible to determine the worth of NeoGenomics on a given historical date. On August 9, 2024 NeoGenomics was worth 17.01 at the beginning of the trading date compared to the closed value of 16.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NeoGenomics stock. Still, in general, we apply an absolute valuation method to find NeoGenomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NeoGenomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NeoGenomics' related companies.
 Open High Low Close Volume
  16.01    16.93    15.80    16.92    643,986  
08/09/2024
  17.01    17.10    16.16    16.55    568,117  
  16.49    16.49    15.90    15.93    500,827  
Backtest NeoGenomics  |  NeoGenomics History  |  NeoGenomics Valuation   PreviousNext  
Open Value
17.01
16.55
Closing Value
24.73
Upside

NeoGenomics Trading Date Momentum on August 9, 2024

On August 12 2024 NeoGenomics was traded for  15.93  at the closing time. Highest NeoGenomics's price during the trading hours was 16.49  and the lowest price during the day was  15.90 . The net volume was 500.8 K. The overall trading history on the 12th of August 2024 contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 3.75% . The trading delta at closing time to current price is 1.81% .

NeoGenomics Fundamentals Correlations and Trends

By evaluating NeoGenomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NeoGenomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NeoGenomics financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About NeoGenomics Stock history

NeoGenomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeoGenomics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeoGenomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeoGenomics stock prices may prove useful in developing a viable investing in NeoGenomics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding125.5 M131.8 M
Net Loss-129.8 M-123.3 M

NeoGenomics Quarterly Net Working Capital

293.83 Million

NeoGenomics Stock Technical Analysis

NeoGenomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NeoGenomics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NeoGenomics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

NeoGenomics Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

NeoGenomics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

NeoGenomics December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how NeoGenomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeoGenomics shares will generate the highest return on investment. By undertsting and applying NeoGenomics stock market strength indicators, traders can identify NeoGenomics entry and exit signals to maximize returns

NeoGenomics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NeoGenomics' price direction in advance. Along with the technical and fundamental analysis of NeoGenomics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeoGenomics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether NeoGenomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeoGenomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neogenomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neogenomics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeoGenomics. If investors know NeoGenomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeoGenomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.306
Earnings Share
(0.60)
Revenue Per Share
5.098
Quarterly Revenue Growth
0.104
Return On Assets
(0.03)
The market value of NeoGenomics is measured differently than its book value, which is the value of NeoGenomics that is recorded on the company's balance sheet. Investors also form their own opinion of NeoGenomics' value that differs from its market value or its book value, called intrinsic value, which is NeoGenomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeoGenomics' market value can be influenced by many factors that don't directly affect NeoGenomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeoGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeoGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeoGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.